Hogy Medical Co.,Ltd. (HGYMF)
USD 24.34
(0.0%)
USD 24.34
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 8.32 Billion JPY | 13906.79% |
| 2023 | 63.49 Million JPY | -8.81% |
| 2022 | 69.63 Million JPY | -12.45% |
| 2021 | 79.52 Million JPY | -5.19% |
| 2020 | 83.88 Million JPY | -1.7% |
| 2019 | 85.34 Million JPY | 9.06% |
| 2018 | 78.25 Million JPY | 6.66% |
| 2017 | 73.36 Million JPY | 5.89% |
| 2016 | 69.28 Million JPY | -99.22% |
| 2015 | 8.87 Billion JPY | -1.41% |
| 2014 | 8.99 Billion JPY | 4.65% |
| 2013 | 8.59 Billion JPY | 2.22% |
| 2012 | 8.41 Billion JPY | 6.75% |
| 2011 | 7.88 Billion JPY | -4.14% |
| 2010 | 8.22 Billion JPY | 2.33% |
| 2009 | 8.03 Billion JPY | 4.53% |
| 2008 | 7.68 Billion JPY | -0.78% |
| 2007 | 7.74 Billion JPY | 5.04% |
| 2006 | 7.37 Billion JPY | 5.26% |
| 2005 | 7 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 2.05 Billion JPY | 12581.37% |
| 2024 FY | 8.32 Billion JPY | 13005.97% |
| 2024 Q1 | 15.88 Million JPY | -2.88% |
| 2024 Q2 | 15.19 Million JPY | -4.38% |
| 2024 Q3 | 16.16 Million JPY | 6.42% |
| 2023 Q4 | 16.35 Million JPY | -10.61% |
| 2023 Q1 | 16.43 Million JPY | -13.2% |
| 2023 FY | 63.49 Million JPY | -8.81% |
| 2023 Q3 | 18.29 Million JPY | 15.18% |
| 2023 Q2 | 15.88 Million JPY | -3.35% |
| 2022 Q4 | 18.93 Million JPY | -8.4% |
| 2022 Q3 | 20.67 Million JPY | -0.34% |
| 2022 FY | 69.63 Million JPY | -12.45% |
| 2022 Q1 | 20.6 Million JPY | -99.2% |
| 2022 Q2 | 20.74 Million JPY | 0.67% |
| 2021 Q2 | 2.33 Billion JPY | -1.15% |
| 2021 Q1 | 2.35 Billion JPY | -9.34% |
| 2021 Q3 | 2.42 Billion JPY | 4.2% |
| 2021 FY | 79.52 Million JPY | -5.19% |
| 2021 Q4 | 2.57 Billion JPY | 6.05% |
| 2020 Q3 | 2.55 Billion JPY | 1.51% |
| 2020 FY | 83.88 Million JPY | -1.7% |
| 2020 Q1 | 2.45 Billion JPY | -12.02% |
| 2020 Q4 | 2.6 Billion JPY | 1.92% |
| 2020 Q2 | 2.51 Billion JPY | 2.24% |
| 2019 FY | 85.34 Million JPY | 9.06% |
| 2019 Q1 | 2.48 Billion JPY | 1.97% |
| 2019 Q2 | 2.57 Billion JPY | 3.78% |
| 2019 Q3 | 2.58 Billion JPY | 0.23% |
| 2019 Q4 | 2.79 Billion JPY | 8.12% |
| 2018 Q4 | 2.43 Billion JPY | 4.5% |
| 2018 Q3 | 2.33 Billion JPY | 4.48% |
| 2018 Q2 | 2.23 Billion JPY | 1.78% |
| 2018 Q1 | 2.19 Billion JPY | -9.57% |
| 2018 FY | 78.25 Million JPY | 6.66% |
| 2017 FY | 73.36 Million JPY | 5.89% |
| 2017 Q2 | 2.21 Billion JPY | 2.4% |
| 2017 Q1 | 2.16 Billion JPY | -3.56% |
| 2017 Q3 | 2.25 Billion JPY | 1.49% |
| 2017 Q4 | 2.42 Billion JPY | 7.73% |
| 2016 Q2 | 2.15 Billion JPY | 1.22% |
| 2016 FY | 69.28 Million JPY | -99.22% |
| 2016 Q3 | 2.26 Billion JPY | 5.15% |
| 2016 Q4 | 2.24 Billion JPY | -0.93% |
| 2016 Q1 | 2.13 Billion JPY | -3.31% |
| 2015 Q2 | 2.24 Billion JPY | 1.67% |
| 2015 Q1 | 2.21 Billion JPY | -5.43% |
| 2015 Q3 | 2.21 Billion JPY | -1.56% |
| 2015 FY | 8.87 Billion JPY | -1.41% |
| 2015 Q4 | 2.2 Billion JPY | -0.41% |
| 2014 Q4 | 2.33 Billion JPY | 1.08% |
| 2014 FY | 8.99 Billion JPY | 4.65% |
| 2014 Q3 | 2.31 Billion JPY | 5.04% |
| 2014 Q2 | 2.2 Billion JPY | 2.42% |
| 2014 Q1 | 2.14 Billion JPY | -3.2% |
| 2013 FY | 8.59 Billion JPY | 2.22% |
| 2013 Q3 | 2.16 Billion JPY | 1.17% |
| 2013 Q4 | 2.22 Billion JPY | 2.73% |
| 2013 Q1 | 2.08 Billion JPY | -6.76% |
| 2013 Q2 | 2.13 Billion JPY | 2.59% |
| 2012 Q3 | 2.09 Billion JPY | 0.34% |
| 2012 FY | 8.41 Billion JPY | 6.75% |
| 2012 Q1 | 2 Billion JPY | 1.62% |
| 2012 Q4 | 2.23 Billion JPY | 6.84% |
| 2012 Q2 | 2.08 Billion JPY | 3.84% |
| 2011 Q2 | 2.06 Billion JPY | 11.12% |
| 2011 Q3 | 1.97 Billion JPY | -4.59% |
| 2011 FY | 7.88 Billion JPY | -4.14% |
| 2011 Q1 | 1.86 Billion JPY | -10.27% |
| 2011 Q4 | 1.97 Billion JPY | 0.0% |
| 2010 Q1 | 2.01 Billion JPY | 4.4% |
| 2010 Q3 | 2.05 Billion JPY | -1.35% |
| 2010 Q2 | 2.07 Billion JPY | 3.18% |
| 2010 FY | 8.22 Billion JPY | 2.33% |
| 2010 Q4 | 2.07 Billion JPY | 1.17% |
| 2009 Q2 | 1.99 Billion JPY | 0.0% |
| 2009 FY | 8.03 Billion JPY | 4.53% |
| 2009 Q3 | 2.03 Billion JPY | 2.36% |
| 2009 Q4 | 1.93 Billion JPY | -5.25% |
| 2008 FY | 7.68 Billion JPY | -0.78% |
| 2007 FY | 7.74 Billion JPY | 5.04% |
| 2006 FY | 7.37 Billion JPY | 5.26% |
| 2005 FY | 7 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -290540.922% |
| Ansell Limited | 495.5 Million USD | -1579.516% |
| Ansell Limited | 495.5 Million USD | -1579.516% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -9950.265% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -480730.342% |
| Psykey, Inc. | 1.21 Million USD | -685696.222% |
| ConvaTec Group Plc | 910.31 Million USD | -814.188% |
| ConvaTec Group Plc | 872.5 Million USD | -853.811% |
| Encision Inc. | 3.77 Million USD | -220248.475% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -5868274.104% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -7570103.127% |
| Innovative MedTech Inc. | 6.09 Million USD | -136348.576% |
| LifePoint, Inc. | 7.42 Million USD | -111997.868% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -130975.76% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -973233.333% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -1145969.458% |
| Reflect Scientific, Inc. | 1.06 Million USD | -782264.184% |
| SmileDirectClub, Inc. | 517 Million USD | -1509.662% |
| Sector 10, Inc. | 39.84 Thousand USD | -20886357.183% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | -25.274% |
| SheerVision, Inc. | 2.33 Million USD | -356816.927% |
| United Health Products, Inc. | 2.42 Million USD | -342857.603% |
| Vasamed, Inc. | 4.67 Million USD | -177990.16% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -324749.208% |
| Yubo International Biotech Limited | 1.25 Million USD | -661491.971% |